1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 5, 2002, Pages 1271-1276

  Tarnawski, Rafal ^a   Sokol, Maria ^a   Pieniazek, Piotr ^a   Maciejewski, Boguslaw ^a   Walecki, Jerzy ^b   Miszczyk, Leszek ^a   Krupska, Teresa ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Brain tumors; Hypoxia; NMR spectroscopy; Prognostic factors

Indexed keywords

IRRADIATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; SURGERY; TUMORS;

NUMERIC INTEGRATION;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; GLIOBLASTOMA; METABOLISM; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SURVIVAL;

DIAGNOSTIC AGENT; HYDROGEN;

ADULT; AGED; BRAIN NEOPLASMS; GLIOBLASTOMA; GLIOMA; HUMANS; HYDROGEN; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036525754     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02769-9     Document Type: Article

References (19)

1. Radiotherapy for high grade gliomas
2. Hyperfractionated and accelerated radiation therapy in central nervous system (malignant gliomas, pediatric tumors, and brain metastases)
3. Final report of phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adult with supratentorial malignant gliomas
4. Imaging of brain tumors after therapy
5. Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patients
6. The conditional probability of survival of patients with primary malignant brain tumors
7. Survival and prognosis of patients with atypical or anaplastic features
8. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients; A report using RTOG 90-06
9. Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children
10. Variation of post-treatment H-MRSI choline intensity in pediatric gliomas
11. 1H MRS studies in vivo
12. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy
13. In vivo single voxel 1H MRS of glial brain tumors; Correlation with tissue histology and in vitro MRS
14. 1H spectroscopy; Glutamate and glutamine, myo-inositol and related metabolites
15. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors
16. Intratumoral lipids in 1H MRS in vivo in brain tumors; Experience of the Siemens cooperative clinical trial
17. Proton magnetic resonance spectroscopy in patients with glial tumors; A multicenter study
18. Mobile lipid accumulation in necrotic tissue of high grade astrocytomas
19. Localized proton spectroscopy of inoperable brain gliomas; Response to radiation therapy